TrialJournal of diabetes investigation2022

Effect of canagliflozin on the decline of estimated glomerular filtration rate in chronic kidney disease patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase III study in Japan.

Takashi Wada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.